Join our efforts to target a better future for the multiple myeloma community
Join our efforts to target a better future for the multiple myeloma community
GSK is driving progress for the multiple myeloma community though new research and therapeutic approaches, as well as programmes within the community. As part of this effort, GSK’s Target the Future Think Tank Challenge grants £85,000 (approximately $100,000) to an individual or non-profit organisation that develops the most innovative idea to address the unmet needs of patients with multiple myeloma.
This year, we're focusing on targeting disparities in multiple myeloma care. While outcomes have dramatically improved for multiple myeloma patients in the last decade, significant needs in education and access remain. These challenges disproportionately affect communities of colour and rural communities, as well as other underserved populations.
Together we can change lives
Learn more about unmet needs from people committed to targeting a better future for the multiple myeloma community.
